<p>Barfresh Food Group，这家消费防御行业公司，昨天被华尔街分析师重新评估。Maxim Group 的分析师 Anthony Vendetti 重申了对该股票的买入评级，并设定了 6.00 美元的目标价。</p>
<h3>认识您的 ETF AI 分析师</h3>
<ul>
<li>发现 TipRanks 的_ETF_ AI 分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong><em>ETF</em> AI 分析师</strong> 对您关注的 ETF 所揭示的见解。</li>
</ul>
<p>Anthony Vendetti 之所以给予买入评级，是由于 Barfresh Food Group 的有前景的收入指引和战略收购等多种因素的综合考虑。尽管该公司第三季度的收入略低于市场预期，但对 2025 年和 2026 年的收入指引重申表明了显著的同比增长，显示出未来表现的强大潜力。</p>
<p>此外，最近收购 Arps Dairy 预计将增强供应稳定性并减少产品缺货，这可能导致运营效率的提高。公司在教育渠道扩展的努力，以及其 Pop &amp; Go 产品的持续成功，进一步支持了积极的前景。尽管在整合和制造方面存在一些短期挑战，但长期增长前景和战略举措证明了买入评级的合理性。</p>
<p>根据 TipRanks，Vendetti 是一位平均回报率为-23.2% 且成功率为 25.86% 的分析师。Vendetti 覆盖医疗保健行业，专注于 Dermata Therapeutics、Lucid Diagnostics 和 Daxor 等股票。</p>

BRFH

<p>Barfresh Food Group 收到了 Maxim Group 分析师 Anthony Vendetti 的买入评级，目标价为 6.00 美元。该评级基于有前景的收入指引和战略收购，尽管第三季度的收入略有失误。公司对 2025 年和 2026 年的指引显示出强劲的增长潜力。收购 Arps Dairy 预计将改善供应稳定性和运营效率。尽管短期内存在整合挑战，但长期前景依然乐观，支持买入评级</p>

<p>Barfresh Food Group, the Consumer Defensive sector company, was revisited by a Wall Street analyst yesterday. Analyst Anthony Vendetti from Maxim Group reiterated a Buy rating on the stock and has a $6.00 price target.</p>
<div class="lb-trans"><p>Barfresh Food Group，这家消费防御行业公司，昨天被华尔街分析师重新评估。Maxim Group 的分析师 Anthony Vendetti 重申了对该股票的买入评级，并设定了 6.00 美元的目标价。</p>
</div><h3>Meet Your ETF AI Analyst</h3>
<div class="lb-trans"><h3>认识您的 ETF AI 分析师</h3>
</div><ul>
<li>Discover how TipRanks' <em>ETF</em> AI Analyst can help you make smarter investment decisions</li>
<li>Explore ETFs TipRanks' users love and see what insights the <strong><em>ETF</em> AI Analyst</strong> reveals about the ones you follow.</li>
</ul>
<div class="lb-trans"><ul>
<li>发现 TipRanks 的_ETF_ AI 分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong><em>ETF</em> AI 分析师</strong> 对您关注的 ETF 所揭示的见解。</li>
</ul>
</div><p>Anthony Vendetti has given his Buy rating due to a combination of factors including Barfresh Food Group’s promising revenue guidance and strategic acquisitions. Despite the company’s third-quarter revenue falling slightly below consensus, the reiterated revenue guidance for 2025 and 2026 suggests significant year-over-year growth, indicating a strong potential for future performance.</p>
<div class="lb-trans"><p>Anthony Vendetti 之所以给予买入评级，是由于 Barfresh Food Group 的有前景的收入指引和战略收购等多种因素的综合考虑。尽管该公司第三季度的收入略低于市场预期，但对 2025 年和 2026 年的收入指引重申表明了显著的同比增长，显示出未来表现的强大潜力。</p>
</div><p>Additionally, the recent acquisition of Arps Dairy is expected to enhance supply stability and reduce product outages, which could lead to improved operational efficiencies. The company’s efforts to expand its presence in the education channel, along with the continued success of its Pop &amp; Go product, further support the positive outlook. Although there are some near-term challenges related to integration and manufacturing, the long-term growth prospects and strategic initiatives justify the Buy rating.</p>
<div class="lb-trans"><p>此外，最近收购 Arps Dairy 预计将增强供应稳定性并减少产品缺货，这可能导致运营效率的提高。公司在教育渠道扩展的努力，以及其 Pop &amp; Go 产品的持续成功，进一步支持了积极的前景。尽管在整合和制造方面存在一些短期挑战，但长期增长前景和战略举措证明了买入评级的合理性。</p>
</div><p>According to TipRanks, Vendetti is an analyst with an average return of -23.2% and a 25.86% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Dermata Therapeutics, Lucid Diagnostics, and Daxor.</p>
<div class="lb-trans"><p>根据 TipRanks，Vendetti 是一位平均回报率为-23.2% 且成功率为 25.86% 的分析师。Vendetti 覆盖医疗保健行业，专注于 Dermata Therapeutics、Lucid Diagnostics 和 Daxor 等股票。</p>
</div>

Barfresh Food Group：战略性收购和乐观的收入指引证明了买入评级的合理性